161 related articles for article (PubMed ID: 23874105)
21. Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcoma.
Golbakhsh MR; Boddouhi B; Hatami N; Goudarzi PK; Shakeri M; Yahaghi E; Taheriazam A
Arch Med Sci; 2017 Oct; 13(6):1352-1356. PubMed ID: 29181065
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression of microRNA-99a and its target gene mTOR associated with malignant progression and poor prognosis in patients with osteosarcoma.
Zhao J; Chen F; Zhou Q; Pan W; Wang X; Xu J; Ni L; Yang H
Onco Targets Ther; 2016; 9():1589-97. PubMed ID: 27073323
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma.
Tang J; Cai H; Lin L; Xie P; Zhong W; Tang M
Clin Transl Oncol; 2013 Jul; 15(7):541-7. PubMed ID: 23143956
[TBL] [Abstract][Full Text] [Related]
24. Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma.
Wang Y; Jia LS; Yuan W; Wu Z; Wang HB; Xu T; Sun JC; Cheng KF; Shi JG
Am J Transl Res; 2015; 7(1):111-9. PubMed ID: 25755833
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients.
Chen K; Pan G
Pathol Res Pract; 2019 Dec; 215(12):152686. PubMed ID: 31711673
[TBL] [Abstract][Full Text] [Related]
26. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
27. MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients.
Zhang F; Huang W; Sheng M; Liu T
Tumour Biol; 2015 Mar; 36(3):2041-8. PubMed ID: 25391425
[TBL] [Abstract][Full Text] [Related]
28. Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis.
Zhu H; Cai H; Tang M; Tang J
Clin Transl Oncol; 2014 Aug; 16(8):732-8. PubMed ID: 24338507
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma.
Tang J; Zhao H; Cai H; Wu H
Biomed Pharmacother; 2015 Apr; 71():222-6. PubMed ID: 25960240
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
Wang G; Shen N; Cheng L; Lin J; Li K
Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
[TBL] [Abstract][Full Text] [Related]
31. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression, metastasis, and unfavorable prognosis of human osteosarcoma.
Azam AT; Bahador R; Hesarikia H; Shakeri M; Yeganeh A
Tumour Biol; 2016 May; 37(5):5769-73. PubMed ID: 26224480
[TBL] [Abstract][Full Text] [Related]
33. Expression of microRNA-150 and its Target Gene IGF2BP1 in Human Osteosarcoma and their Clinical Implications.
Wang L; Aireti A; Aihaiti A; Li K
Pathol Oncol Res; 2019 Apr; 25(2):527-533. PubMed ID: 30220021
[TBL] [Abstract][Full Text] [Related]
34. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients' prognosis.
Zhu H; Tang J; Tang M; Cai H
Diagn Pathol; 2013 Nov; 8():183. PubMed ID: 24188461
[TBL] [Abstract][Full Text] [Related]
36. The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma.
Sun B; Yang M; Li M; Wang F
Biomed Pharmacother; 2015 Apr; 71():58-63. PubMed ID: 25960216
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma.
Chu Y; Hu X; Wang G; Wang Z; Wang Y
Oncol Lett; 2019 Jun; 17(6):5210-5218. PubMed ID: 31186737
[TBL] [Abstract][Full Text] [Related]
38. Reduced expression of miR-564 is associated with worse prognosis in patients with osteosarcoma.
Gao F; Xu F
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5851-5856. PubMed ID: 30280765
[TBL] [Abstract][Full Text] [Related]
39. miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma.
Dong J; Liu Y; Liao W; Liu R; Shi P; Wang L
J Bone Oncol; 2016 Jun; 5(2):74-9. PubMed ID: 27335775
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
